Pharmacovigilance is responsible for the collection, assessment, identification, and communication of all drug safety information. In addition, PV focuses on the processing of safety information, adverse event reporting, and keeping up to date with guidelines and regulations.
The Pharmacovigilance Oversight and Inspection Readiness Virtual Summit will focus on how to achieve safety inspection readiness through effective partner collaboration and quality optimization strategies.
Speaking
Faculty
Josue Bautista Arteaga
Janaina Brothers
Helena Van Den Dungen
Kal Elhoregy
Garry Flounders
Siva Kumar
Randy Levitt
Carla Massironi
Jaylaxmi Nalawade
Raphael Pareschi
Sameer Thapar
Top Reasons to PURCHASE
Analyze the importance of a Culture of Quality and its impact on safety
Learn tools to “survive” Inspections and Audits
Ensure streamline communication between partners, CROs and sponsors
Leverage learnings and challenges from PV audits to promote and ensure inspection readiness
Discuss new ICH guidelines and their effect on drug safety and pharmacovigilance
Recognize the value of PV systems to streamline communication and achieve inspection readiness
Bridging the gap between PV innovation and PV quality – Level the play field for every drug safety stakeholder
WHO SHOULD PURCHASE
This event is designed for pharmaceutical, biotech, and medical device professionals with responsibilities in the following areas:
- Pharmacovigilance
- Safety & Risk management
- Drug safety
- PV Compliance
- Safety Surveillance
- Medical Affairs
- Regulatory Affairs
- Inspection and Audit
- Pharmacoepidemiology
- Post-market studies
- Medical product safety assessment
- Drug Research & Development
- Clinical Pharmacology
- Medical information
- Health outcomes